2023-09-21 | Company

Sever Pharma Solutions breaks ground with new high potency drug manufacturing suites

[Putnam, CT, USA - Sever Pharma Solutions, a leading pharmaceutical contract development and manufacturing organization (CDMO), has announced the groundbreaking of its new high potency active pharmaceutical ingredients (HPAPI) manufacturing suites.

Read more

2023-09-13 | Company

Tony Listro interviewed in Drug Development & Delivery

Tony Listro, Vice President of Technology and Site Lead for SPS’s North American site in Putnam, CT, discusses the company’s recent focus areas and current expansion plans.

Read more

2023-07-07 | Company

Sustainability report 2022

Sustainability is front and center for a company of our kind. Subsequently, Sever Pharma Solutions is entirely focused on human health and well-being. Read the full sustainability report.

Read more

2022-10-13 | Company

Company report 2021

Our goal is to build a global CDMO with a niche strategy. There are few high-potency product manufacturers, and almost no one works with polymer implants. Read the full company report.

Read more

2022-08-03 | Company

New global HR Director

Jessica Jonasson is our new Global HR Director. Jessica enters a global role that will encompass activities at all Sever Pharma Solutions sites, involving all human resources aspects of the CDMO group.

Read more